Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children

• Egile Nagusiak: Piyada Angsuwatcharakon (Egilea), Sumana Khomvilai (Egilea), Kornvika Limsuwun (Egilea), Natchaya Ratananpinit (Egilea), Apinya Khamchat (Egilea), Teeranit Sanitnai (Egilea), Terapong Tantawichien (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2018-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: Children are at risk of rabies exposure in many Asian countries. The safety and immunogenicity profile of the WHO-approved two-site intradermal Thai Red Cross regimen (modified TRC-ID regimen; 2-2-2-0-2) with a new chromatographically purified Vero-cell rabies vaccine (CPRV) is lacking...